Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Change in Cash: 2013-2020

Historic Change in Cash for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to -$33.2 million.

  • Larimar Therapeutics' Change in Cash fell 635.91% to -$33.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $68.5 million, marking a year-over-year increase of 2121.79%. This contributed to the annual value of $5.7 million for FY2024, which is 7647.37% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Change in Cash of -$33.2 million as of Q4 2020, which was down 191.77% from -$11.4 million recorded in Q3 2020.
  • In the past 5 years, Larimar Therapeutics' Change in Cash registered a high of $113.1 million during Q2 2020, and its lowest value of -$33.2 million during Q4 2020.
  • Its 3-year average for Change in Cash is $6.1 million, with a median of $2.0 million in 2019.
  • Data for Larimar Therapeutics' Change in Cash shows a peak YoY increase of 1,221.40% (in 2020) and a maximum YoY decrease of 635.91% (in 2020) over the last 5 years.
  • Over the past 5 years, Larimar Therapeutics' Change in Cash (Quarterly) stood at $7.5 million in 2016, then soared by 188.13% to $21.6 million in 2017, then crashed by 80.59% to $4.2 million in 2018, then tumbled by 207.54% to -$4.5 million in 2019, then crashed by 635.91% to -$33.2 million in 2020.
  • Its Change in Cash was -$33.2 million in Q4 2020, compared to -$11.4 million in Q3 2020 and $113.1 million in Q2 2020.